UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000021585
Receipt No. R000024896
Scientific Title A phase II study of eribulin in combination with trastuzumab and pertuzumab as First-Line therapy for metastatic HER2-positive breast cancer
Date of disclosure of the study information 2016/03/23
Last modified on 2018/12/18 20:02:14

No. Disposal Last modified on Item of update
1 Insert 2016/03/23 19:45:22
2 Update 2018/12/18 20:02:14 Recruitment status


Contact us.